Frances E. Pearson
Impact in
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Immunology 12
- Immunotherapy and Immune Responses 12
- T-cell and B-cell Immunology 2
- Oncology 5
- CAR-T cell therapy research 4
- Co-authors
- M. A. F. Kendall (5 shared papers)Kristen J. Radford (7 shared papers)Ingrid Leal Rojas (7 shared papers)Adrian V. S. Hill (3 shared papers)Oscar Haigh (6 shared papers)Conor O’Mahony (2 shared papers)Celia L. McNeilly (2 shared papers)Anne Moore (2 shared papers)
- Journals
- Scientific Reports (2 papers)Vaccine (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)PLoS ONE (2 papers)Immunology and Cell Biology (1 paper)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Frances E. Pearson
16 papers receiving 553 citations
Peers
Comparison fields: 5 of 63
- Pharmaceutical Science 206
- Immunology 343
- Dermatology 104
- Biotechnology 46
- Infectious Diseases 73
Countries citing papers authored by Frances E. Pearson
This map shows the geographic impact of Frances E. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frances E. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frances E. Pearson more than expected).
Fields of papers citing papers by Frances E. Pearson
This network shows the impact of papers produced by Frances E. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frances E. Pearson. The network helps show where Frances E. Pearson may publish in the future.
Co-authors
The 25 scholars most cited alongside Frances E. Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 80 | |
| 2 | 2017 | 73 | |
| 3 | 2011 | 72 | |
| 4 | 2013 | 59 | |
| 5 | 2021 | 39 | |
| 6 | 2016 | 38 | |
| 7 | 2018 | 34 | |
| 8 | 2020 | 33 | |
| 9 | 2020 | 31 | |
| 10 | 2015 | 30 | |
| 11 | 2016 | 26 | |
| 12 | Potency assays for novel T-cell-inducing vaccines against malaria. | 2009 | 23 |
| 13 | 2015 | 17 | |
| 14 | 2018 | 3 | |
| 15 | 2021 | 1 | |
| 16 | 2020 | 1 |
About Frances E. Pearson
Frances E. Pearson is a scholar working on Immunology, Oncology, Pharmaceutical Science, Molecular Biology and Dermatology, having authored 16 papers that have together received 560 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (12 papers), Advancements in Transdermal Drug Delivery (4 papers), CAR-T cell therapy research (4 papers), Dermatology and Skin Diseases (2 papers), T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), vaccines and immunoinformatics approaches (2 papers) and Health Literacy and Information Accessibility (1 paper). The work is most often cited by research in Pharmaceutical Science (206 citations), Immunology (343 citations), Dermatology (104 citations), Biotechnology (46 citations) and Infectious Diseases (73 citations). Frances E. Pearson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include M. A. F. Kendall, Kristen J. Radford, Ingrid Leal Rojas, Adrian V. S. Hill, Oscar Haigh, Conor O’Mahony, Celia L. McNeilly, Anne Moore, Germain J. P. Fernando and Jacob W. Coffey. Their work appears in journals such as Scientific Reports, Vaccine, Journal for ImmunoTherapy of Cancer, PLoS ONE and Immunology and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.